The state of New Jersey currently has 17 active clinical trials seeking participants for Diabetes research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
NCT06623396
Recruiting
Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory at Memorial Sloan Kettering to be changed (modified) to become MSLN-targeted CAR T cells, the CAR T-cell therapy that participants will receive during the study. Participant study therapy will take about 3-4 weeks.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/01/2024
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey +2 locations
Conditions: Mesothelin Positive, Mesothelin-Expressing Tumors, Esophageal Adenocarcinoma, Esophageal Adenocarcinomas, Esophagogastric Adenocarcinoma, Peritoneal Carcinomatosis, Breast Neoplasms, Diabetes Mellitus
Register for Updates
Exercise and Time of Day in Type 2 Diabetes
NCT05108987
Recruiting
The overall purpose of the study is to test the effect of Noom on exercise and diet advice in adults with type 2 diabetes. The overarching hypothesis is that the use of Noom may promote better dietary adherence during an exercise program, thereby promoting greater weight loss and cardiometabolic health compared to lifestyle advice only. In particular, the investigators anticipate that changes in metabolic and vascular insulin sensitivity will correlate with glycemic control and blood pressure ch... Read More
Gender:
ALL
Ages:
Between 30 years and 70 years
Trial Updated:
08/06/2024
Locations: New Jersey Institute for Food, Nutrition, and Health, New Brunswick, New Jersey +2 locations
Conditions: Diabetes Mellitus, Type 2, Metabolic Syndrome
Register for Updates
Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2
NCT03933696
Recruiting
To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).
Gender:
All
Ages:
55 years and above
Trial Updated:
06/03/2024
Locations: Rutgers University, New Brunswick, New Jersey
Conditions: Mild Cognitive Impairment, Alzheimer Disease, Type2 Diabetes
Register for Updates
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
NCT04011020
Recruiting
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals worldwide have T1D, and incidence increases annually. Several recent clinical trials point to the need for an approach that produces comprehensive immune modulation at both the local pancreatic and systemic levels. Stem Cell Educator (SCE) therapy offers comprehensive immune modulation at both the local and systemic levels in T1D by using a patient's own imm... Read More
Gender:
All
Ages:
14 years and above
Trial Updated:
04/25/2024
Locations: Hackensack Meridian Health, Hackensack, New Jersey +1 locations
Conditions: Type 1 Diabetes
Register for Updates
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT05785780
Recruiting
This mixed methods study evaluates the effectiveness and feasibility of a multi-level (patient, team, organizations) intervention to optimize CRC screening for patients with diabetes in primary care safety-net settings.
Gender:
All
Ages:
Between 50 years and 74 years
Trial Updated:
10/19/2023
Locations: RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey
Conditions: Colorectal Cancer Screening, Diabetes Mellitus, Type 2
Register for Updates